| 0 (0%) | 08-27 07:23 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 22.78 |
1-year : | 26.61 |
| Resists | First : | 19.51 |
Second : | 22.78 |
| Pivot price | 18.12 |
|||
| Supports | First : | 17.56 |
Second : | 16.37 |
| MAs | MA(5) : | 17.47 |
MA(20) : | 17.97 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | -0.4 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 38.4 |
D(3) : | 26.3 |
| RSI | RSI(14): 51.5 |
|||
| 52-week | High : | 28.22 | Low : | 16.37 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ KLRA ] has closed below upper band by 38.3%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 18.48 - 18.57 | 18.57 - 18.65 |
| Low: | 17.16 - 17.26 | 17.26 - 17.35 |
| Close: | 18.27 - 18.44 | 18.44 - 18.59 |
Wed, 26 Aug 2026
Top Kailera Therapeutics (KLRA) Competitors 2026 - MarketBeat
Tue, 25 Aug 2026
Weekly Update: Kailera Therapeutics: Tirzepatide-Class Data, Retatrutide-Class Ambitions, IPO-Price Entry - Seeking Alpha
Tue, 25 Aug 2026
Kailera Therapeutics (NASDAQ:KLRA) Trading 8.6% Higher - Here's Why - MarketBeat
Tue, 18 Aug 2026
KLRA Archives - 24/7 Wall St.
Mon, 17 Aug 2026
Kailera Therapeutics (KLRA) Reports Wider Losses And Names New CTO, Is The Low P B Justified? - Yahoo Finance
Fri, 14 Aug 2026
Canada Pension Plan (KLRA) discloses 5.6% Kailera Therapeutics ownership in 13G filing - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 130 (M) |
| Shares Float | 58 (M) |
| Held by Insiders | 8.8 (%) |
| Held by Institutions | 89.6 (%) |
| Shares Short | 6,630 (K) |
| Shares Short P.Month | 5,100 (K) |
| EPS | -2.25 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.63 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -2.42 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -222 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -8.2 |
| PEG Ratio | 0 |
| Price to Book value | 2.13 |
| Price to Sales | 0 |
| Price to Cash Flow | -10.79 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|